4-Bromo-1-(2,4-dichlorobenzyl)-1H-pyrazol-3-amine

Catalog No. :
ACQRJJ591
CAS No. :
895929-80-3
Molecular Formula :
C10H8BrCl2N3
Molecular Weight :
321.01

IUPAC Name:4-bromo-1-(2,4-dichlorobenzyl)-1H-pyrazol-3-amine

4-Bromo-1-(2,4-dichlorobenzyl)-1H-pyrazol-3-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$261.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Bromo-1-(2,4-dichlorobenzyl)-1H-pyrazol-3-amine
IUPAC Name4-bromo-1-(2,4-dichlorobenzyl)-1H-pyrazol-3-amine
MDL No.MFCD03422540
Molecular FormulaC10H8BrCl2N3
Molecular Weight321.01
SMILESNC1=NN(CC2=CC=C(Cl)C=C2Cl)C=C1Br
InChI KeyOATKBYPVLQFGTF-UHFFFAOYSA-N
Synonym4-bromo-1-(2,4-dichlorobenzyl)-1H-pyrazol-3-amine hydrochloride;1H-pyrazol-3-amine, 4-bromo-1-[(2,4-dichlorophenyl)methyl];4-bromo-1-[(2,4-dichlorophenyl)methyl]pyrazol-3-amine;4-bromo-1-[(2,4-dichlorophenyl)methyl]-1H-pyrazol-3-amine;4-Bromo-1-(2,4-dichlorobenzyl)-1,2-dihydro-3h-pyrazol-3-imine
CAS No.895929-80-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACQRJJ591 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWAQR615 route compound structure diagram
    ACWAQR61516461-94-2 In Stock
  4. Then
  5. ACQRJJ591 route product structure diagram
    ACQRJJ591895929-80-3
Inquiry

2. ACQRJJ591 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOWGM620 route compound structure diagram
    ACOWGM62020443-99-6 In Stock
  2. Plus
  3. ACWAQR615 route compound structure diagram
    ACWAQR61516461-94-2 In Stock
  4. Then
  5. ACQRJJ591 route product structure diagram
    ACQRJJ591895929-80-3
Inquiry

Comments (0)